Biotechnology

Biotechnology Patient Care Drug Efficacy Venture Capital Mergers and Acquisitions Type 2 Diabetes Drug Development Partnerships Drug Development Cancer Research

3 ARTICLES

last wk.

Novo Nordisk Partners with Septerna in $2.2 Billion Deal for Oral Obesity Therapies

The collaboration aims to develop four GPCR-targeted small-molecule treatments, diversifying Novo Nordisk’s portfolio amid rising competition from Eli Lilly.

3 ARTICLES

2mo ago

AstraZeneca Acquires Belgian Biotech EsoBiotec in $1 Billion Deal